Evaluation of Reporting of Immune Checkpoint Inhibitor Associated Cardio-vascular Adverse Reactions
Clinical trial NCT03387540 · COMPLETED
Trial details
- NCT number
- NCT03387540
- Sponsor
- Groupe Hospitalier Pitie-Salpetriere
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2017-12-02
- Primary completion
- 2017-12-04
- Enrollment
- 104
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.